IART
Integra Lifesciences Holdings·NASDAQ
--
--(--)
--
--(--)
IART fundamentals
Integra Lifesciences Holdings (IART) released its earnings on Feb 26, 2026: revenue was 434.93M (YoY -1.74%), beat estimates; EPS was 0.83 (YoY -14.43%), beat estimates.
Revenue / YoY
434.93M
-1.74%
EPS / YoY
0.83
-14.43%
Report date
Feb 26, 2026
IART Earnings Call Summary for Q4,2025
- Revenue Resilience: Q4 2025 revenue $435 million, adjusted EPS $0.83, beating guidance. Full-year 2025 organic growth constrained by supply but demand strong.
- 2026 Growth Drivers: Braintree facility launch in Q2 2026 to enable SurgiMend relaunch. CMS changes align with portfolio, pricing within new reimbursement ranges.
- Financial Improvement: 2026 free cash flow expected to exceed $200 million, up $150 million from 2025, driven by reduced capital spending and operational efficiency.
- Tariff Uncertainty: 2026 guidance excludes potential Section 122 tariff recovery, with 2025 tariffs impact of $0.32 per share.
Earnings
EPS
Revenue
Revenue & Expenses
IART has released its 2025 Q4 earnings report, with revenue of 434.93M, reflecting a YoY change of -1.74%, and net profit of -1.70M, showing a YoY change of -108.77%. The Sankey diagram below clearly presents IART's revenue sources and cost distribution.
Key Indicators
Integra Lifesciences Holdings (IART) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Integra Lifesciences Holdings (IART)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Integra Lifesciences Holdings (IART)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Integra Lifesciences Holdings (IART)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Integra Lifesciences Holdings (IART) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Integra Lifesciences Holdings (IART) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Integra Lifesciences Holdings year over year?What guidance did Integra Lifesciences Holdings's management provide for the next earnings period?What is the market's earnings forecast for Integra Lifesciences Holdings next quarter?What is Integra Lifesciences Holdings's gross profit margin?What were the key takeaways from Integra Lifesciences Holdings’s earnings call?What is Integra Lifesciences Holdings's latest dividend and current dividend yield?What factors drove the changes in Integra Lifesciences Holdings's revenue and profit?What were the key takeaways from Integra Lifesciences Holdings's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
